低氧诱导因子:氧稳态的砝码——2019年诺贝尔生理学或医学奖简介

首都医科大学学报 ›› 2019, Vol. 40 ›› Issue (5): 805-809.

低氧诱导因子:氧稳态的砝码——2019年诺贝尔生理学或医学奖简介

焦时宇, 于宝琪, 曲爱娟

首都医科大学基础医学院生理学与病理生理学系重塑相关心血管疾病教育部重点实验室, 北京 100069

收稿日期:2019-10-12 出版日期:2019-09-21 发布日期:2019-12-16
通讯作者: 曲爱娟 E-mail:aijuanqu@ccmu.edu.cn

Hypoxia inducible factor: a weight to balance the oxygen homeostasis—introduction of Nobel Prize in Physiology or Medicine 2019

Jiao Shiyu, Yu Baoqi, Qu Aijuan

Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University; Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing 100069, China

Received:2019-10-12 Online:2019-09-21 Published:2019-12-16

摘要/Abstract

摘要： 北京时间2019年10月7日，瑞典卡罗琳斯卡医学院在斯德哥尔摩宣布将2019年诺贝尔生理学或医学奖授予美国科学家William G.Kaelin和Gregg L.Semenza，以及英国科学家Peter J.Ratcliffe，以表彰他们在理解细胞感知和适应氧气变化机制中的贡献。

关键词: 2019年诺贝尔生理学或医学奖, 氧气感知机制, 低氧诱导因子

Abstract: On October 7, 2019, Beijing time, the Karolinska Institute of Sweden announced in Stockholm that the 2019 Nobel Prize in Physiology or Medicine was awarded to American scientists William G. Kaelin, Gregg L. Semenza, and the British scientist Peter J. Ratcliffe in recognition of their contribution in understanding cellular perception and adaptation to oxygen changes.

Key words: the 2019 Nobel Prize in Physiology or Medicine, oxygen-sensing, hypoxia inducible factor

焦时宇, 于宝琪, 曲爱娟. 低氧诱导因子:氧稳态的砝码——2019年诺贝尔生理学或医学奖简介[J]. 首都医科大学学报, 2019, 40(5): 805-809.

Jiao Shiyu, Yu Baoqi, Qu Aijuan. Hypoxia inducible factor: a weight to balance the oxygen homeostasis—introduction of Nobel Prize in Physiology or Medicine 2019[J]. Journal of Capital Medical University, 2019, 40(5): 805-809.

参考文献

[1] Antonarakis S E. Hypoxia-inducible nuclear factors bind to an enhancer element located 3'to the human erythropoietin gene[J]. Proc Natl Acad Sci U S A, 1991, 88(13):5680-5684.
[2] Wang G L, Jiang B H, Rue E A, et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension[J]. Proc Natl Acad Sci U S A, 1995,92(12):5510-5514.
[3] Maxwell P H, Wiesener M S, Chang G W, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis[J]. Nature, 1999,399(6733):271-275.
[4] Kim W Y, Kaelin W G. Role of VHL gene mutation in human cancer[J]. J Clin Oncol, 2004,22(24):4991-5004.
[5] Jiang Y, Zhang W, Kondo K, et al. Gene expression profiling in a renal cell carcinoma cell line:dissecting VHL and hypoxia-dependent pathways[J]. Mol Cancer Res, 2003, 1(6):453-462.
[6] Cockman M E, Masson N, Mole D R, et al. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein[J]. J Biol Chem, 2000,275(33):25733-25741.
[7] Ivan M, Kondo K, Yang H, et al. HIF alpha targeted for VHL-mediated destruction by proline hydroxylation:implications for O2 sensing[J]. Science, 2001,292(5516):464-468.
[8] Jaakkola P, Mole D R, Tian Y M, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolylhydroxylation[J]. Science, 2001, 292(5516):468-472.
[9] Wang G L, Semenza G L, Purification and characterization of hypoxia-inducible factor 1[J]. J Biol Chem, 1995, 270(3):1230-1237.
[10] Pugh C W, O'Rourke J F, Nagao M, et al. Activation of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit[J]. J Biol Chem, 1997,272(17):11205-11214.
[11] Davis C K, Jain S A, Bae O N, et al. Hypoxia mimetic agents for ischemic stroke[J]. Front Cell Dev Biol, 2019,6:175.
[12] Semenza G L. O2-regulated gene expression:transcriptional control of cardiorespiratory physiology by HIF-1[J]. J Appl Physiol (1985), 2004,96(3):1173-1177.
[13] Li Q F, Dai A G. Hypoxia-inducible factor-1 alpha regulates the role of vascular endothelial growth factor on pulmonary arteries of rats with hypoxia-induced pulmonary hypertension[J]. Chin Med J (Engl), 2004,117(7):1023-1028.
[14] Vink A, Schoneveld A H, Lamers D, et al. HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages[J]. Atherosclerosis, 2007,195(2):e69-e75.